Advertisement

Topics

Clinical Genomics Pty Ltd Company Profile

03:46 EDT 22nd October 2018 | BioPortfolio

Clinical Genomics is dedicated to improving patient outcomes through early detection of colorectal cancer. Clinical Genomics products span the full spectrum of colorectal cancer testing, lnSure® ONE™, a one sample fecal immunochemical test (FIT) for healthy adults to detect lower GI bleeding, and COLVERA®, a proprietary liquid biopsy blood test identifying circulating tumor DNA for detection of residual disease and early detection of recurrence in post-treatment patients. Clinical Genomics is committed to developing and delivering solutions that provide physicians and their patients with information to help guide earlier and better treatment decisions in cancer care management. Clinical Genomics continues to apply its proprietary innovation in molecular pathology to commercialize other diagnostic tools in other cancer types.


News Articles [619 Associated News Articles listed on BioPortfolio]

QUANTUM GENOMICS: Quantum Genomics receives ethics committee approval to initiate clinical study of extended-release firibastat tablets

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat hypertension and h...

Iqvia inks genomics deal to advance discovery of precision meds

Iqvia says its collaboration with Genomics England will help drugmakers and academics draw insights from clinical-genomic datasets â the âfuture of real-world research.â

5 Ways SmartTrials is Advancing Precision Medicine Through Genomics

  Foundation Medicine’s Dr. Gaurav Singal shares how his company’s platform is changing the game in clinical trials and bolstering precision medicine through genomics. The evolution may be slow g...

Clinical Genomics completes $26mm second round

Liquid biopsy developer Clinical Genomics Pty. Ltd. raised $26mm through what is assumed to be its Series B round. New investors Moelis Australia Asset Management and Regal were joined by returning ba...

Clinical Genomics Presents Clinical Utility Data for COLVERA™ at 2018 ASCO Annual Meeting

BRIDGEWATER, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer (CRC) testing and solutions, today announced that data demonstrating the utility of CO...

UCSF Names First Chief Genomics Officer

David RathsRecognizing that genomics is playing an increasingly important role in medicine, the University of California San Francisco Health has appointed its first chief genomics officer (CGO).

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

Drugs and Medications [0 Results]

None

PubMed Articles [1661 Associated PubMed Articles listed on BioPortfolio]

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Challenges and opportunities for effective delivery of clinical genetic services in the U.S. healthcare system.

Demand for clinical genetics and genomics services is increasing. As discussed in this study, the clinical genetics and genomics workforce is small. How to meet the demand with a limited workforce req...

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.

Bladder cancer has numerous genomic features that are potentially actionable by targeted agents. Nevertheless, both pre-clinical and clinical research using molecular targeted agents have been very li...

Increasing nursing capacity in genomics: Overview of existing global genomics resources.

Global genomic literacy of all health professions, including nurses, remains low despite an inundation of genomic information with established clinical and analytic validity and clinical utility. Geno...

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.

We characterized associations between central nervous system (CNS) adverse events and brain neurotransmitter transporter/receptor genomics among participants randomized to efavirenz-containing regimen...

Clinical Trials [1662 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology

This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injur...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

Epidemiologic Multicentre Study of Neuropathic Post-Surgical Pain

This cohort study aims to know the prevalence at 3 and 6 months after surgery, of persistent pain, as well as to describe the neuropathic features of this pain. It includes more than 3000 ...

Companies [1815 Associated Companies listed on BioPortfolio]

Clinical Genomics Pty Ltd

Clinical Genomics is dedicated to improving patient outcomes through early detection of colorectal cancer. Clinical Genomics products span the full spectrum of colorectal cancer t...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

AKESOgen, Inc.

AKESOgen is an integrated genomics and pharmacogenetics company providing biorepository services and high-throughput, biomarker profiling and genomics analysis utilizing different...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Clinical Genomics Pty Ltd" on BioPortfolio

We have published hundreds of Clinical Genomics Pty Ltd news stories on BioPortfolio along with dozens of Clinical Genomics Pty Ltd Clinical Trials and PubMed Articles about Clinical Genomics Pty Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clinical Genomics Pty Ltd Companies in our database. You can also find out about relevant Clinical Genomics Pty Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record